NCT02043561

Brief Summary

The aim of this study will be to investigate the effect of rectal distension, controlled by electronic barostat, on cognitive control ability in healthy subjects. We will use the Stroop task and an intertemporal choice task as standard instruments. Like bladder control and rectal control, both Stroop task performance and intertemporal choices - though very different tasks at the surface - are dependent on the conflict monitoring function of the anterior cingulate cortex. The Stroop task requires the naming of the print color of a series of visually presented color words, and reaction time and error rates are typically used as performance indicators. When word color and word meaning do not match, performance of the task (color naming) requires the inhibition of a (near) automatic response (word reading). The intertemporal choice task consists of a series of choices between a sooner smaller monetary reward and a larger but later reward. The choices are constructed such that they allow the estimation of a discount parameter, which is an index for the level of impulsiveness manifested by the participant at the time the choices are made. The hypothesis is that the inhibition induced by the urge generated during rectal distension will improve cognitive inhibitory performance, as has previously been shown for bladder filling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 23, 2014

Completed
11 months until next milestone

Study Start

First participant enrolled

December 24, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2015

Completed
Last Updated

September 11, 2017

Status Verified

January 1, 2014

Enrollment Period

9 months

First QC Date

January 17, 2014

Last Update Submit

September 7, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • cognitive inhibitory performance on Stroop task (reaction time, in milliseconds) and intertemporal choice task (discount parameter, no unit)

    * response reaction time on Stroop task * discount parameter on intertemporal choice task

    30 minutes

Study Arms (3)

no urge

SHAM COMPARATOR

rectal balloon deflated

Other: induction of urge by rectal distension

moderate urge

EXPERIMENTAL

moderate urge induced by rectal balloon

Other: induction of urge by rectal distension

high urge

EXPERIMENTAL

high urge induced by rectal balloon

Other: induction of urge by rectal distension

Interventions

high urgemoderate urgeno urge

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy male and non-pregnant, non-breastfeeding female participants, aged 18-60 years old at the time of consent.

You may not qualify if:

  • use of medications within 48 h of dose initiation; structural or metabolic diseases that affect the gastrointestinal system and functional gastrointestinal disorders; previous abdominal surgery other than appendectomy, cholecystectomy, hysterectomy, or hernia repair; known illnesses such as diabetes, cardiovascular or lung disease; current psychiatric disorders (anxiety, depression, substance use); use of agents that influence bowel habit, i.e. anticholinergics (not including antihistamines with anticholinergic properties), spasmolytics and prokinetics in the 7 days before the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Leuven, campus Gasthuisberg

Leuven, 3000, Belgium

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2014

First Posted

January 23, 2014

Study Start

December 24, 2014

Primary Completion

September 7, 2015

Study Completion

September 7, 2015

Last Updated

September 11, 2017

Record last verified: 2014-01

Locations